Fidelity Investments’s Kezar Life Sciences KZR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$104K Buy
22,665
+8,360
+58% +$38.3K ﹤0.01% 3596
2025
Q1
$69.8K Buy
14,305
+5,904
+70% +$28.8K ﹤0.01% 3710
2024
Q4
$56.5K Buy
8,401
+8,080
+2,517% +$54.3K ﹤0.01% 3791
2024
Q3
$2.48K Sell
321
-5,908
-95% -$45.7K ﹤0.01% 4753
2024
Q2
$37.4K Buy
6,229
+4,020
+182% +$24.1K ﹤0.01% 3767
2024
Q1
$19.9K Buy
2,209
+358
+19% +$3.23K ﹤0.01% 4018
2023
Q4
$17.5K Buy
1,851
+1,120
+153% +$10.6K ﹤0.01% 4007
2023
Q3
$8.7K Sell
731
-3,186
-81% -$37.9K ﹤0.01% 4156
2023
Q2
$96K Sell
3,917
-163
-4% -$3.99K ﹤0.01% 3180
2023
Q1
$128K Sell
4,080
-4,473
-52% -$140K ﹤0.01% 3120
2022
Q4
$602K Sell
8,553
-2,802
-25% -$197K ﹤0.01% 2663
2022
Q3
$978K Buy
11,355
+26
+0.2% +$2.24K ﹤0.01% 2612
2022
Q2
$937K Buy
11,329
+7,306
+182% +$604K ﹤0.01% 2688
2022
Q1
$669K Buy
+4,023
New +$669K ﹤0.01% 2900
2021
Q2
Sell
-134,674
Closed -$8.03M 4598
2021
Q1
$8.03M Sell
134,674
-51,899
-28% -$3.09M ﹤0.01% 2115
2020
Q4
$9.74M Hold
186,573
﹤0.01% 1981
2020
Q3
$9.03M Sell
186,573
-7,180
-4% -$348K ﹤0.01% 1865
2020
Q2
$10M Sell
193,753
-50,687
-21% -$2.63M ﹤0.01% 1809
2020
Q1
$10.7M Sell
244,440
-42,685
-15% -$1.86M ﹤0.01% 1674
2019
Q4
$11.5M Buy
287,125
+5,982
+2% +$240K ﹤0.01% 1800
2019
Q3
$9.22M Sell
281,143
-5,648
-2% -$185K ﹤0.01% 1867
2019
Q2
$22.1M Buy
286,791
+11,158
+4% +$860K ﹤0.01% 1581
2019
Q1
$48.9M Sell
275,633
-9,290
-3% -$1.65M 0.01% 1226
2018
Q4
$67.2M Buy
284,923
+31,885
+13% +$7.52M 0.01% 1031
2018
Q3
$54.2M Buy
253,038
+102,780
+68% +$22M 0.01% 1234
2018
Q2
$26M Buy
+150,258
New +$26M ﹤0.01% 1605